Overview

NI-0801 in Allergic Contact Dermatitis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the effect of a single dose of NI-0801 on the severity of nickel-induced allergic contact dermatitis.
Phase:
Phase 1
Details
Lead Sponsor:
NovImmune SA